Revenue: As of FY2025 Q1, the actual value is USD 59.82 M.EPS: As of FY2025 Q1, the actual value is USD 0.07.EBIT: As of FY2025 Q1, the actual value is USD 53.65 M.<h3>Segment Revenue</h3><ul><li>Net Sales: The Company’s net sales for the three months ended March 31, 2025 decreased by $44.2 million, or 42%, to $59.8 million compared to $104.0 million for the three months ended March 31, 2024. The decrease was driven by the deconsolidation of Holdings on February 28, 2025.</li></ul><h3>Operational Metrics</h3><ul><li>Gross Profit: The Company’s gross profit for the three months ended March 31, 2025 decreased $26.5 million, or 48%, to $28.7 million compared to $55.2 million for the three months ended March 31, 2024, while the gross profit margin decreased from 53% to 48%.</li><li>Operating Expenses: The Company’s operating expenses for the three months ended March 31, 2025 decreased $1.4 million, or 6%, to $22.7 million compared to $24.1 million for the three months ended March 31, 2024.</li><li>Income from Operations: During the three months ended March 31, 2025, the Company had income from operations of $6.0 million compared to income from operations of $31.1 million for the three months ended March 31, 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operations: Cash provided by the Company’s operating activities for the three months ended March 31, 2025 was $3.0 million as compared to cash provided by its operating activities of $33.8 million during the three months ended March 31, 2024.</li><li>Net Cash Used in Investing: Cash used in the Company’s investing activities for the three months ended March 31, 2025 was $60.7 million, primarily related to cash and cash equivalents that were deconsolidated as a result of the Spin-Off, compared to cash used in investing activities for the three months ended March 31, 2024 of $1.6 million.</li><li>Net Cash Used in Financing: Cash used in the Company’s financing activities for the three months ended March 31, 2025 was $10.3 million, compared to cash used in the Company’s financing activities for the three months ended March 31, 2024 of $18.2 million.</li></ul><h3>Unique Metrics</h3><ul><li>Earnings in Equity Method Investment: Earnings in CompoSecure Holdings, L.L.C. equity method investment consists of $14.8 million of net income of Holdings attributable to the Company.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The Company believes that Holdings’ cash flows from its operations and available cash and cash equivalents at March 31, 2025 of $9.5 million as well as its available $130.0 million under the 2024 Revolver, are sufficient to meet the liquidity needs of Holdings and the Company, including the repayment by Holdings of its outstanding debt, for at least the next 12 months.</li><li>Non-Core Business: The Company completed the previously-announced spin-off of Resolute Holdings on February 28, 2025, which resulted in the deconsolidation of Holdings and the adoption of equity method accounting presentation for Holdings.</li></ul>

CompoSecure - CW25 | 10-Q: FY2025 Q1 Revenue: USD 59.82 M